Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00115232 · ClinicalTrials.gov registry record
Inflammatory Profiles of Children at High Risk for Atherosclerosis
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 300
- Enrollment target
NCT00115232 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 300 participants.
The verdict
NCT00115232 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate levels of inflammatory mediators in children at risk for cardiovascular disease due to family history. We are measuring inflammatory markers in two groups of children and their parents: children with a family history of early atherosclerotic heart disease (cases), and healthy children without such a family history (controls). The design is a cross-sectional study, gathering a fasting blood sample and clinical and behavioral data on children and a parent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00115232
The ClinicalTrials.gov registry entry for NCT00115232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00115232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00115232 about?
NCT00115232 is a clinical study titled "Inflammatory Profiles of Children at High Risk for Atherosclerosis". The purpose of this study is to evaluate levels of inflammatory mediators in children at risk for cardiovascular disease due to family history. We are measuring inflammatory markers in two groups of children and their parents: children with a family history of early atherosclerotic heart disease (ca...
What is the current status of trial NCT00115232?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2004-07. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00115232?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.